ImmunityBio Inc.
(IBRX)
undefined
undefined%
At close: undefined
2.91
1.93%
After-hours Dec 13, 2024, 07:58 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 622.00K | 240.00K | 934.00K | 605.00K | 2.20M | 47.00K | 45.00K | 44.00K | 236.00K | 641.00K | 600.00K |
Cost of Revenue | - | 24.19M | - | 9.15M | 9.01M | -3.11M | - | - | - | - | 253.00K |
Gross Profit | 622.00K | -23.95M | 934.00K | -8.54M | -6.81M | 3.16M | 45.00K | 44.00K | 236.00K | 641.00K | 347.00K |
Operating Income | -362.25M | -351.30M | -330.28M | -220.88M | -156.25M | -98.39M | -99.12M | -124.50M | -238.88M | -6.21M | -2.27M |
Interest Income | 863.00K | 2.71M | 836.00K | 1.73M | 2.76M | - | - | - | - | - | 2.00K |
Pretax Income | -583.89M | -417.29M | -349.84M | -226.03M | -160.26M | -96.73M | -96.92M | -121.38M | -237.18M | -6.21M | -2.05M |
Net Income | -583.20M | -417.32M | -349.85M | -224.19M | -160.16M | -96.23M | -96.42M | -120.81M | -236.88M | -6.21M | -2.05M |
Selling & General & Admin | 129.62M | 102.71M | 135.26M | 71.32M | 46.46M | 35.46M | 53.82M | 94.39M | 226.21M | 4.33M | 2.42M |
Research & Development | 232.37M | 248.15M | 195.96M | 139.51M | 112.00M | 53.42M | 39.78M | 26.55M | 11.43M | 1.59M | 446.00K |
Other Expenses | 886.00K | -736.00K | 193.00K | 1.49M | -534.00K | - | - | - | - | - | - |
Operating Expenses | 362.87M | 350.86M | 331.21M | 210.82M | 158.45M | 88.88M | 93.60M | 120.94M | 237.64M | 5.92M | 2.87M |
Interest Expense | 129.20M | 63.52M | 14.85M | 9.07M | 5.92M | 433.00K | 618.00K | 66.00K | - | - | 463.00K |
Selling & Marketing Expenses | - | - | - | - | - | 7.07M | -3.30M | -1.00M | -1.47M | - | - |
Cost & Expenses | 362.87M | 350.86M | 331.21M | 210.82M | 158.45M | 98.44M | 99.17M | 124.54M | 239.11M | 6.24M | 2.87M |
Income Tax | -40.00K | 34.00K | 9.00K | -1.85M | -105.00K | -503.00K | -493.00K | -572.00K | -301.00K | 1K | 1K |
Shares Outstanding (Basic) | 508.64M | 399.90M | 389.23M | 383.18M | 383.18M | 79.13M | 80.58M | 81.98M | 71.52M | 315.73M | 797.11K |
Shares Outstanding (Diluted) | 508.64M | 399.90M | 389.23M | 383.18M | 383.18M | 79.13M | 80.58M | 81.98M | 71.52M | 315.73M | 797.11K |
EPS (Basic) | -1.15 | -1.04 | -0.9 | -0.59 | -0.42 | -1.22 | -1.2 | -1.47 | -3.31 | -0.02 | -2.57 |
EPS (Diluted) | -1.15 | -1.04 | -0.9 | -0.59 | -0.42 | -1.22 | -1.2 | -1.47 | -3.31 | -0.02 | -2.57 |
EBITDA | -436.18M | -335.51M | -315.38M | -187.93M | -142.27M | -86.74M | -90.73M | -117.71M | -235.71M | -5.68M | -1.58M |
Depreciation & Amortization | 18.51M | 24.19M | 19.12M | 9.15M | 9.01M | 9.55M | 5.57M | 3.61M | 1.47M | 128.00K | 4.00K |